drugset / Trial / NCT06036914
A Study of Ultra High Dose Diuretics to Treat Heart Failure
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the safety and effectiveness of ultrahigh dose diuretics compared to standard dose diuretics over 24 hours in patients with decompensated heart failure.
Timeline
- Start
- 2023-11-27
- Primary completion
- 2024-10-08
- Completion
- 2024-10-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bumetanide | Small molecule | 12.5 mg | Intravenous |
| Comparator | Furosemide | Other / unclassified | 40 mg | Intravenous |
| Comparator | Furosemide | Other / unclassified | 100 mg | Intravenous |